-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KKSbdOqhcZroTtqbwiECLZ+Zpd3f8DZFpyGEjS/6lJzGfzQ7vij2oa7dx74gWaYW Gsy/iT+6bf77RvzkOCKzlQ== 0000926372-96-000012.txt : 19960315 0000926372-96-000012.hdr.sgml : 19960315 ACCESSION NUMBER: 0000926372-96-000012 CONFORMED SUBMISSION TYPE: 10-C/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19960314 FILED AS OF DATE: 19960314 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: PUREPAC INC/ CENTRAL INDEX KEY: 0000729069 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042769995 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-C/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-13588 FILM NUMBER: 96534575 BUSINESS ADDRESS: STREET 1: 200 ELMORA AVE CITY: ELIZABETH STATE: NJ ZIP: 07207 BUSINESS PHONE: 9085279100 MAIL ADDRESS: STREET 1: 200 ELMORA AVENUE STREET 2: 200 ELMORA AVENUE CITY: ELIZABETH STATE: NJ ZIP: 07207 FORMER COMPANY: FORMER CONFORMED NAME: MOLECULON INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: MOLECULON BIOTECH INC DATE OF NAME CHANGE: 19860417 10-C/A 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ---------------------- Form 10-C/A REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ INTERDEALER QUOTATION SYSTEM Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and Rule 13a-17 or 15d-17 thereunder Purepac, Inc. (Exact name of issuer as specified in charter) 200 Elmora Avenue, Elizabeth, New Jersey 07207 (Address of principal executive offices) (908) 527-9100 (Issuer's telephone number, including area code) 1. CHANGE IN NUMBER OF SHARES OUTSTANDING Indicate any change (increase or decrease) of 5% or more in the number of shares outstanding: 1. Title of security: Common Stock 2. Number of shares outstanding before the change: 12,615,223 3. Number of shares outstanding after the change: 15,125,539 4. Effective date of change: February 29, 1996 5. Method of change: Acquisition Specify method (such as merger, acquisition, exchange, distribution, stock split, reverse split, acquisition of stock for treasury, etc.) Give brief description of transaction: The Registrant acquired from its majority stockholder, Faulding Holdings Inc. ("Faulding"), all of the capital stock of each of Faulding Puerto Rico, Inc., a Delaware corporation, Faulding Pharmaceutical Co., a Delaware corporation, and Faulding Medical Device Co., a Delaware corporation, each a wholly-owned subsidiary of Faulding (collectively, the "Acquired Companies"), for 2,510,316 shares of the Registrant's Common Stock, subject to adjustment as a result of an audit of the net asset value of the Acquired Companies at February 29, 1996. II. CHANGE IN NAME OF ISSUER 1. Name prior to change: Purepac, Inc. 2. Name after change: Faulding Inc. 3. Effective date of charter amendment changing name: February 29, 1996 4. Date of shareholder approval of change, if required: February 29, 1996 Date: March 14, 1996 /s/Richard F. Moldin -------------------- Richard F. Moldin President and Chief Executive Officer -----END PRIVACY-ENHANCED MESSAGE-----